Annual SG&A
$3.56 M
-$93.10 K-2.55%
01 December 2023
Summary:
Xenetic Biosciences annual selling, general & administrative expenses is currently $3.56 million, with the most recent change of -$93.10 thousand (-2.55%) on 01 December 2023. During the last 3 years, it has risen by +$160.80 thousand (+4.73%). XBIO annual SG&A is now -48.67% below its all-time high of $6.94 million, reached on 31 December 2017.XBIO Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$745.70 K
-$384.30 K-34.01%
01 September 2024
Summary:
Xenetic Biosciences quarterly selling, general & administrative expenses is currently $745.70 thousand, with the most recent change of -$384.30 thousand (-34.01%) on 01 September 2024. Over the past year, it has increased by +$8500.00 (+1.15%). XBIO quarterly SG&A is now -75.01% below its all-time high of $2.98 million, reached on 30 September 2015.XBIO Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$779.51 M
-$4.08 M-0.53%
01 September 2024
Summary:
Xenetic Biosciences TTM selling, general & administrative expenses is currently -$779.51 million, with the most recent change of -$4.08 million (-0.53%) on 01 September 2024. Over the past year, it has dropped by -$782.97 million (-22590.10%). XBIO TTM SG&A is now -1399373.43% below its all-time high of $7.63 million, reached on 30 June 2016.XBIO TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XBIO Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.5% | +1.1% | -10000.0% |
| 3 y3 years | +4.7% | -21.1% | -10000.0% |
| 5 y5 years | -18.9% | -65.2% | -10000.0% |
XBIO Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -4.9% | +4.7% | -34.0% | +1.1% | -9.0% | at low |
| 5 y | 5 years | -24.7% | +4.7% | -65.2% | +1.1% | -24.0% | at low |
| alltime | all time | -48.7% | +3023.6% | -75.0% | +6618.0% | <-9999.0% | at low |
Xenetic Biosciences Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $745.70 K(-34.0%) | $3.66 M(+0.2%) |
| June 2024 | - | $1.13 M(+35.3%) | $3.65 M(+5.3%) |
| Mar 2024 | - | $834.90 K(-12.3%) | $3.47 M(-2.5%) |
| Dec 2023 | $3.56 M(-2.5%) | $952.00 K(+29.1%) | $3.56 M(+2.7%) |
| Sept 2023 | - | $737.20 K(-22.1%) | $3.47 M(-3.5%) |
| June 2023 | - | $945.90 K(+2.2%) | $3.59 M(-2.2%) |
| Mar 2023 | - | $925.70 K(+8.0%) | $3.67 M(+0.5%) |
| Dec 2022 | $3.65 M(-2.4%) | $857.20 K(-0.7%) | $3.65 M(-3.2%) |
| Sept 2022 | - | $863.20 K(-15.9%) | $3.77 M(-2.1%) |
| June 2022 | - | $1.03 M(+13.1%) | $3.86 M(+3.6%) |
| Mar 2022 | - | $907.30 K(-7.2%) | $3.72 M(-0.6%) |
| Dec 2021 | $3.74 M(+10.1%) | $977.60 K(+3.4%) | $3.74 M(+2.7%) |
| Sept 2021 | - | $945.10 K(+6.1%) | $3.65 M(+4.0%) |
| June 2021 | - | $890.70 K(-4.3%) | $3.51 M(+3.0%) |
| Mar 2021 | - | $930.60 K(+5.7%) | $3.40 M(+0.1%) |
| Dec 2020 | $3.40 M(-28.1%) | $880.60 K(+9.5%) | $3.40 M(+1.4%) |
| Sept 2020 | - | $804.10 K(+2.1%) | $3.35 M(-28.5%) |
| June 2020 | - | $787.50 K(-15.1%) | $4.69 M(-2.2%) |
| Mar 2020 | - | $927.90 K(+11.2%) | $4.80 M(+1.4%) |
| Dec 2019 | $4.73 M(+7.7%) | $834.50 K(-61.1%) | $4.73 M(-5.8%) |
| Sept 2019 | - | $2.14 M(+140.5%) | $5.02 M(+26.9%) |
| June 2019 | - | $890.80 K(+3.2%) | $3.96 M(-4.3%) |
| Mar 2019 | - | $863.40 K(-23.2%) | $4.13 M(-5.9%) |
| Dec 2018 | $4.39 M(-36.7%) | $1.12 M(+4.2%) | $4.39 M(-16.4%) |
| Sept 2018 | - | $1.08 M(+1.2%) | $5.26 M(-4.8%) |
| June 2018 | - | $1.07 M(-5.0%) | $5.52 M(-14.1%) |
| Mar 2018 | - | $1.12 M(-43.6%) | $6.43 M(-7.4%) |
| Dec 2017 | $6.94 M | $1.99 M(+48.0%) | $6.94 M(-5.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | $1.34 M(-31.8%) | $7.30 M(-0.2%) |
| June 2017 | - | $1.97 M(+20.6%) | $7.32 M(+6.0%) |
| Mar 2017 | - | $1.63 M(-30.5%) | $6.90 M(+3.2%) |
| Dec 2016 | $6.69 M(+4.8%) | $2.35 M(+73.0%) | $6.69 M(+11.5%) |
| Sept 2016 | - | $1.36 M(-12.7%) | $6.00 M(-21.3%) |
| June 2016 | - | $1.56 M(+9.5%) | $7.63 M(+11.0%) |
| Mar 2016 | - | $1.42 M(-14.6%) | $6.88 M(+7.6%) |
| Dec 2015 | $6.39 M(-3.2%) | $1.66 M(-44.2%) | $6.39 M(+4.4%) |
| Sept 2015 | - | $2.98 M(+271.5%) | $6.12 M(+41.1%) |
| June 2015 | - | $803.40 K(-14.1%) | $4.34 M(-15.6%) |
| Mar 2015 | - | $935.20 K(-33.0%) | $5.14 M(-22.1%) |
| Dec 2014 | $6.60 M(+2.1%) | $1.40 M(+16.1%) | $6.60 M(+25.4%) |
| Sept 2014 | - | $1.20 M(-25.1%) | $5.27 M(+28.3%) |
| June 2014 | - | $1.61 M(-32.9%) | $4.10 M(+62.1%) |
| Mar 2014 | - | $2.39 M(+3844.3%) | $2.53 M(+1612.4%) |
| Dec 2013 | $6.46 M(+5571.0%) | - | - |
| Nov 2013 | - | $60.70 K(+46.3%) | $147.80 K(+29.6%) |
| Aug 2013 | - | $41.50 K(+20.3%) | $114.00 K(-10.7%) |
| Aug 2013 | $114.00 K(-96.8%) | - | - |
| May 2013 | - | $34.50 K(+210.8%) | $127.60 K(-11.4%) |
| Feb 2013 | - | $11.10 K(-58.7%) | $144.00 K(-19.6%) |
| Dec 2012 | $3.56 M(+1949.4%) | - | - |
| Nov 2012 | - | $26.90 K(-51.2%) | $179.20 K(+3.1%) |
| Aug 2012 | - | $55.10 K(+8.3%) | $173.80 K(+46.4%) |
| Aug 2012 | $173.80 K | - | - |
| May 2012 | - | $50.90 K(+9.9%) | $118.70 K(+75.1%) |
| Feb 2012 | - | $46.30 K(+115.3%) | $67.80 K(+215.3%) |
| Nov 2011 | - | $21.50 K | $21.50 K |
FAQ
- What is Xenetic Biosciences annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Xenetic Biosciences?
- What is Xenetic Biosciences annual SG&A year-on-year change?
- What is Xenetic Biosciences quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Xenetic Biosciences?
- What is Xenetic Biosciences quarterly SG&A year-on-year change?
- What is Xenetic Biosciences TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Xenetic Biosciences?
- What is Xenetic Biosciences TTM SG&A year-on-year change?
What is Xenetic Biosciences annual selling, general & administrative expenses?
The current annual SG&A of XBIO is $3.56 M
What is the all time high annual SG&A for Xenetic Biosciences?
Xenetic Biosciences all-time high annual selling, general & administrative expenses is $6.94 M
What is Xenetic Biosciences annual SG&A year-on-year change?
Over the past year, XBIO annual selling, general & administrative expenses has changed by -$93.10 K (-2.55%)
What is Xenetic Biosciences quarterly selling, general & administrative expenses?
The current quarterly SG&A of XBIO is $745.70 K
What is the all time high quarterly SG&A for Xenetic Biosciences?
Xenetic Biosciences all-time high quarterly selling, general & administrative expenses is $2.98 M
What is Xenetic Biosciences quarterly SG&A year-on-year change?
Over the past year, XBIO quarterly selling, general & administrative expenses has changed by +$8500.00 (+1.15%)
What is Xenetic Biosciences TTM selling, general & administrative expenses?
The current TTM SG&A of XBIO is -$779.51 M
What is the all time high TTM SG&A for Xenetic Biosciences?
Xenetic Biosciences all-time high TTM selling, general & administrative expenses is $7.63 M
What is Xenetic Biosciences TTM SG&A year-on-year change?
Over the past year, XBIO TTM selling, general & administrative expenses has changed by -$782.97 M (-22590.10%)